ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.1% | 573 | -98.4% | 0.00% | – |
| Q1 2022 | $54,000 | -30.8% | 36,073 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -39.5% | 36,073 | -0.4% | 0.00% | – |
| Q3 2021 | $129,000 | -53.8% | 36,212 | -25.6% | 0.00% | – |
| Q2 2021 | $279,000 | +11.6% | 48,693 | +1.2% | 0.00% | – |
| Q1 2021 | $250,000 | +166.0% | 48,100 | +22.1% | 0.00% | – |
| Q4 2020 | $94,000 | +70.9% | 39,400 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -26.7% | 39,400 | 0.0% | 0.00% | – |
| Q2 2020 | $75,000 | +200.0% | 39,400 | +294.0% | 0.00% | – |
| Q1 2020 | $25,000 | +8.7% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +9.5% | 10,000 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | -79.0% | 10,000 | -75.0% | 0.00% | – |
| Q2 2019 | $100,000 | +203.0% | 40,000 | +154.8% | 0.00% | – |
| Q1 2018 | $33,000 | -54.8% | 15,700 | 0.0% | 0.00% | – |
| Q4 2017 | $73,000 | -38.7% | 15,700 | 0.0% | 0.00% | – |
| Q3 2017 | $119,000 | +45.1% | 15,700 | 0.0% | 0.00% | – |
| Q2 2017 | $82,000 | +30.2% | 15,700 | +15.7% | 0.00% | – |
| Q1 2016 | $63,000 | – | 13,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |